Evaluation_NN of_IN Dipstick_NP Serologic_NP Tests_NP for_IN Diagnosis_NN of_IN Brucellosis_NP and_CC Typhoid_NP Fever_NP in_IN Egypt_NP Two_NP dipstick_NN assays_NNS for_IN the_DT detection_NN of_IN Brucella-_NP and_CC typhoid-specific_JJ immunoglobulin_NN M_NN ,_, recently_RB developed_VBN by_IN the_DT Royal_NP Tropical_NP Institute_NP of_IN The_DT Netherlands_NP ,_, were_VBD evaluated_VBN by_IN use_NN of_IN 85_CD plasma_NN samples_NNS from_IN Egyptian_JJ patients_NNS ._SENT Both_DT dipsticks_NNS were_VBD simple_JJ and_CC accurate_JJ rapid_JJ diagnostic_JJ assays_NNS ,_, and_CC they_PP can_MD be_VB useful_JJ adjuncts_NNS for_IN the_DT diagnosis_NN of_IN typhoid_JJ fever_NN and_CC brucellosis_NN ._SENT Typhoid_JJ fever_NN and_CC brucellosis_NN are_VBP frequent_JJ causes_NNS of_IN bloodstream_NN infections_NNS in_IN many_JJ countries_NNS ._SENT The_DT diagnosis_NN of_IN these_DT infections_NNS is_VBZ challenging_VBG because_IN they_PP can_MD have_VB diverse_JJ clinical_JJ manifestations_NNS with_IN symptoms_NNS that_WDT overlap_VBP with_IN a_DT wide_JJ spectrum_NN of_IN other_JJ diseases_NNS ._SENT Cultures_NNS of_IN blood_NN or_CC bone_NN marrow_NN are_VBP the_DT most_RBS definitive_JJ diagnostic_JJ methods_NNS ._SENT In_IN many_JJ developing_VBG countries_NNS ,_, both_CC diseases_NNS are_VBP diagnosed_VBN on_IN clinical_JJ grounds_NNS and_CC treated_VBN empirically_RB ._SENT Serology_NN assays_NNS are_VBP often_RB utilized_VBN as_IN a_DT diagnostic_JJ tool_NN ;_: however_RB ,_, neither_CC the_DT Widal_NP nor_CC the_DT Brucella_NP agglutination_NN assay_NN is_VBZ sufficiently_RB sensitive_JJ ,_, specific_JJ ,_, or_CC practical_JJ in_IN areas_NNS of_IN endemicity_NN ._SENT In_IN this_DT study_NN ,_, we_PP evaluated_VBD the_DT sensitivity_NN and_CC specificity_NN of_IN the_DT Royal_NP Tropical_NP Institute_NP of_IN The_DT Netherlands_NP (_( RTI_NP )_) dipstick_NN assay_NN ._SENT Representative_JJ plasma_NN samples_NNS were_VBD originally_RB collected_VBN from_IN patients_NNS admitted_VBD to_TO five_CD infectious_JJ disease_NN hospitals_NNS in_IN Egypt_NP according_VBG to_TO certain_JJ case_NN definitions_NNS and_CC laboratory_NN tests_NNS using_VBG conventional_JJ blood_NN culture_NN and_CC serological_JJ techniques_NNS ._SENT Eighty-five_JJ plasma_NN samples_NNS were_VBD screened_VBN by_IN Widal_NP and_CC Brucella_NP agglutination_NN assays_NNS ._SENT The_DT remaining_VBG portions_NNS were_VBD preserved_VBN at_IN -70C_NN for_IN evaluation_NN with_IN the_DT dipstick_NN assay_NN ,_, which_WDT was_VBD performed_VBN within_IN 2_CD to_TO 3_CD months_NNS postadmission_NN ._SENT Results_NNS were_VBD related_VBN to_TO the_DT other_JJ findings_NNS for_IN the_DT purpose_NN of_IN this_DT study_NN ._SENT Among_IN those_DT patients_NNS ,_, 25_CD had_VBD blood_NN culture-proven_NNS typhoid_JJ fever_NN ,_, 25_CD had_VBD blood_NN culture-proven_NN brucellosis_NN ,_, 25_CD had_VBD acute_JJ fever_NN but_CC negative_JJ blood_NN cultures_NNS and_CC serology_NN ,_, and_CC 10_CD had_VBD negative_JJ blood_NN cultures_NNS but_CC were_VBD seroreactive_JJ to_TO Widal_NP (_( n_NN =_SYM 5_CD )_) or_CC Brucella_NP (_( n_NN =_SYM 5_CD )_) agglutination_NN ._SENT The_DT RTI_NP dipstick_NN assay_NN is_VBZ based_VBN on_IN the_DT binding_NN of_IN human_JJ Brucella-_NP or_CC Salmonella_NP enterica_NP serovar_NP Typhi-specific_NP immunoglobulin_NN M_NP (_( IgM_NP )_) antibodies_NNS with_IN the_DT respective_JJ antigen_NN ,_, which_WDT is_VBZ detected_VBN with_IN an_DT anti-human_NP IgM_NP dye_NN conjugate_JJ ._SENT IgM_NP has_VBZ been_VBN reported_VBN to_TO appear_VB a_DT few_JJ days_NNS after_IN infection_NN ,_, reaching_VBG a_DT peak_NN within_IN 3_CD to_TO 4_CD weeks_NNS ,_, and_CC then_RB it_PP declines_VBZ gradually_RB over_IN a_DT similar_JJ period_NN of_IN time_NN ._SENT The_DT test_NN sample_NN was_VBD incubated_VBN for_IN 2_CD h_NN at_IN 35C_JJ ._SENT The_DT built-in_JJ internal_JJ control_NN band_NN provided_VBD a_DT check_NN on_IN the_DT integrity_NN of_IN the_DT detection_NN reagent_NN and_CC the_DT presence_NN of_IN serum_NN ._SENT To_TO avoid_VB bias_NN ,_, investigators_NNS were_VBD blinded_VBN to_TO the_DT blood_NN culture_NN results_NNS until_IN the_DT dipstick_NN assays_NNS were_VBD completed_VBN ._SENT Blood_NN culture_NN results_NNS were_VBD considered_VBN the_DT "_`` gold_JJ standard_NN "_'' and_CC were_VBD used_VBN to_TO determine_VB the_DT positive_JJ and_CC negative_JJ results_NNS by_IN dipstick_NN assays_NNS ._SENT Of_IN the_DT 30_CD patients_NNS with_IN laboratory-confirmed_JJ brucellosis_NN (_( 25_CD culture_NN positive_JJ and_CC 5_CD positive_NN by_IN tube_NN agglutination_NN test_NN )_) ,_, 28_CD tested_VBD positive_JJ by_IN the_DT Brucella_NP dipstick_NN (_( 93_CD %_NN sensitivity_NN )_) ._SENT Additionally_RB ,_, the_DT Brucella_NP dipstick_NN was_VBD positive_JJ for_IN 4_CD of_IN 55_CD serum_NN samples_NNS that_WDT were_VBD negative_JJ by_IN culture_NN and_CC Brucella_NP agglutination_NN testing_NN (_( specificity_NN =_SYM 93_CD %_NN )_) ._SENT Of_IN the_DT 30_CD patients_NNS with_IN a_DT laboratory_NN diagnosis_NN of_IN typhoid_JJ fever_NN (_( 25_CD culture_NN positive_JJ plus_IN 5_CD Widal_JJ positive_NN )_) ,_, 27_CD had_VBD a_DT positive_JJ dipstick_NN test_NN (_( sensitivity_NN =_SYM 90_CD %_NN )_) ._SENT The_DT typhoid_JJ dipstick_NN was_VBD positive_JJ in_IN only_RB 2_CD of_IN 55_CD samples_NNS derived_VBN from_IN patients_NNS without_IN laboratory_NN evidence_NN of_IN typhoid_JJ fever_NN (_( specificity_NN =_SYM 96_CD %_NN )_) ._SENT Table_NN shows_VBZ that_IN readings_NNS of_IN the_DT Brucella_NP agglutination_NN test_NN and_CC dipstick_NN assay_NN were_VBD the_DT same_JJ ,_, recognizing_VBG titers_NNS >=160_JJ in_IN 92_CD %_NN of_IN samples_NNS collected_VBN from_IN culture-positive_JJ patients_NNS ._SENT However_RB ,_, in_IN the_DT case_NN of_IN typhoid_JJ fever_NN ,_, the_DT Widal_JJ test_NN was_VBD negative_JJ for_IN 8_CD of_IN 22_CD (_( 32_CD %_NN )_) dipstick-positive_JJ specimens_NNS ,_, suggesting_VBG a_DT lower_JJR sensitivity_NN or_CC titer_NN (_( <160)._TABLE =1:160_JJ ._SENT Ten_CD samples_NNS (_( 100_CD %_NN )_) from_IN patients_NNS with_IN a_DT negative_JJ blood_NN culture_NN but_CC serologic_JJ evidence_NN by_IN Widal_NP or_CC Brucella_NP agglutination_NN reacted_VBD with_IN the_DT respective_JJ dipsticks_NNS ._SENT Since_IN the_DT typhoid_JJ dipstick_NN assay_NN was_VBD based_VBN on_IN IgM_NP detection_NN in_IN acute_JJ infections_NNS ,_, antibodies_NNS peculiar_JJ to_TO chronic_JJ carriers_NNS (_( anti-Vi-specific_NP IgG_NP )_) could_MD not_RB be_VB detected_VBN ._SENT Passive_JJ hemagglutination_NN or_CC enzyme-linked_JJ immunosorbent_JJ assays_NNS have_VBP been_VBN advocated_VBN for_IN such_JJ discrimination_NN in_IN epidemiological_JJ surveys_NNS ._SENT The_DT RTI_NP dipstick_NN test_NN is_VBZ a_DT simple_JJ ,_, fast_RB ,_, and_CC reliable_JJ method_NN for_IN the_DT diagnosis_NN of_IN typhoid_JJ fever_NN and_CC brucellosis_NN and_CC confirmed_VBD results_NNS from_IN previous_JJ studies_NNS ._SENT With_IN sensitivity_NN and_CC specificity_NN of_IN both_DT dipsticks_NNS in_IN excess_NN of_IN 90_CD %_NN ,_, the_DT kits_NNS performed_VBD well_RB in_IN settings_NNS where_WRB both_DT brucellosis_NN and_CC typhoid_JJ fever_NN are_VBP endemic_JJ ._SENT Published_JJ studies_NNS suggest_VBP that_IN blood_NN cultures_NNS are_VBP positive_JJ in_IN only_RB approximately_RB 60_CD %_NN of_IN patients_NNS with_IN brucellosis_NN or_CC typhoid_JJ fever_NN ._SENT The_DT findings_NNS that_IN culture-negative_JJ patients_NNS were_VBD positive_JJ by_IN dipsticks_NNS may_MD be_VB useful_JJ in_IN settings_NNS where_WRB antibiotic_JJ use_NN is_VBZ high_JJ and_CC no_DT cultures_NNS are_VBP available_JJ ._SENT One_CD concern_NN noted_VBD with_IN dipstick_NN kits_NNS was_VBD that_IN 16_CD %_NN of_IN the_DT patients_NNS with_IN culture-proven_NN brucellosis_NN reacted_VBD with_IN the_DT typhoid_JJ dipstick_NN and_CC 8_CD %_NN of_IN the_DT samples_NNS from_IN patients_NNS with_IN culture-proven_JJ typhoid_JJ fever_NN reacted_VBN with_IN the_DT Brucella_NP dipstick_NN ._SENT The_DT reason_NN for_IN both_DT dipstick_NN tests_NNS having_VBG a_DT positive_JJ reaction_NN from_IN a_DT single_JJ patient_NN is_VBZ not_RB clear_JJ ,_, but_CC in_IN addition_NN to_TO simple_JJ cross-reactivity_NN ,_, potential_JJ options_NNS could_MD include_VB recent_JJ past_JJ infection_NN with_IN one_CD organism_NN and_CC current_JJ infection_NN with_IN the_DT second_JJ organism_NN or_CC persistence_NN of_IN IgM_NP antibodies_NNS in_IN some_DT patients_NNS ._SENT Another_DT interesting_JJ finding_NN was_VBD the_DT high_JJ correlation_NN (_( 100_CD %_NN )_) between_IN serological_JJ results_NNS and_CC the_DT dipstick_NN assay_NN results_NNS from_IN patients_NNS with_IN clinically_RB suspected_VBN brucellosis_NN or_CC typhoid_JJ fever_NN among_IN patients_NNS who_WP had_VBD negative_JJ blood_NN cultures_NNS ._SENT However_RB ,_, for_IN patients_NNS with_IN positive_JJ cultures_NNS ,_, the_DT sensitivity_NN of_IN the_DT typhoid_JJ dipstick_NN was_VBD found_VBN to_TO be_VB significantly_RB higher_JJR than_IN that_DT of_IN the_DT corresponding_JJ serological_JJ results_NNS ._SENT The_DT relatively_RB low_JJ sensitivity_NN of_IN the_DT Widal_JJ test_NN in_IN this_DT study_NN may_MD have_VB resulted_VBN from_IN an_DT undetectable_JJ level_NN of_IN IgM_NP antibody_NN ,_, which_WDT was_VBD probably_RB due_JJ to_TO the_DT young_JJ age_NN of_IN patients_NNS and/or_CC a_DT relatively_RB short_JJ length_NN of_IN illness_NN of_IN the_DT typhoid_JJ patients_NNS ._SENT For_IN the_DT purpose_NN of_IN communicable_JJ disease_NN surveillance_NN ,_, the_DT Ministry_NP of_IN Health_NP in_IN Egypt_NP indicated_VBD that_IN tube_NN agglutination_NN titers_NNS >=1/160_NN are_VBP to_TO be_VB regarded_VBN as_RB positive_JJ for_IN brucellosis_NN and_CC typhoid_JJ fever_NN ._SENT This_DT is_VBZ based_VBN on_IN extensive_JJ clinical_JJ and_CC laboratory_NN findings_NNS collected_VBN over_IN a_DT number_NN of_IN years_NNS ._SENT Consequently_RB ,_, the_DT dipstick_NN assay_NN would_MD not_RB be_VB expected_VBN to_TO show_VB false-positive_JJ results_NNS ,_, given_VBN the_DT results_NNS of_IN positive_JJ ,_, negative_JJ ,_, and_CC control_NN samples_NNS of_IN this_DT study_NN ._SENT However_RB ,_, the_DT Brucella_NP dipstick_NN assay_NN showed_VBD 8_CD %_NN cross-reactivity_NN with_IN typhoid_JJ patients_NNS who_WP had_VBD no_DT evidence_NN of_IN Brucella_NP infection_NN ,_, but_CC the_DT corresponding_JJ agglutination_NN titers_NNS were_VBD considerably_RB lower_JJR than_IN the_DT cutoff_NN ._SENT Our_PP$ preliminary_JJ results_NNS are_VBP quite_RB promising_JJ and_CC lead_VB us_PP to_TO recommend_VB the_DT use_NN of_IN the_DT dipstick_NN assays_VBZ in_IN the_DT primary_JJ characterization_NN of_IN infection_NN ._SENT Being_VBG specific_JJ ,_, faster_JJR ,_, and_CC easier_JJR than_IN conventional_JJ methods_NNS ,_, they_PP could_MD be_VB of_IN value_NN in_IN areas_NNS where_WRB diagnostic_JJ capabilities_NNS for_IN culture_NN and_CC serology_NN are_VBP poor_JJ ._SENT 